바로가기 메뉴
본문내용 바로가기

2016년 심혈관 춘계통합학술대회 제8회 아시아 · 태평양 심부전 학술대회

학회별 일정

E [Vascular] Apr. 19 (Fri.) 09:30-11:00 103 (1F)
Vascular Aging and Cardiovascular Risk Assessment
Panel Sung Ae Kim, Chi Young Shim, Eun Joo Cho
09:30-09:50 Noninvasive Assessment of Arterial Stiffness: Recent Updates Si Hyuck Kang / Seoul National Univ., Korea
09:50-10:10 Cardiovascular Risk Assessment in Asians: Challenges and Opportunities Eugene Yang / Univ. of Washington, USA
10:10-10:30 Impact of Arterial Stiffness on Cardiac Function and Outcome Hack Lyoung Kim / Seoul National Univ., Korea
10:30-10:50 Impact of Arterial Stiffness on Renal Function and Outcome Chan Joo Lee / Yonsei Univ., Korea
10:50-11:00 Discussion
[Myocardial Infarction 1] Apr. 19 (Fri.) 09:30-11:00 106 (1F)
Myocardial Infarction: What's New in AMI?
Chairperson(s)채성철, 정명호
Panel 박종선, 배장환, 이장훈, 장기육, 황진용
09:30-09:45 A New Identifying and Classifying AMI; Case-Based Approach 윤혁준 / 계명의대
09:45-10:00 Optimizing DAPT Duration after AMI; Case-Based Approach 박용휘 / 경상의대
10:00-10:15 How to Limit Infarct Size in STEMI? 강현재 / 서울의대
10:15-10:30 Hemodynamic Support: Which Device for Which Patient and Why? 장우진 / 이화의대
10:30-11:00 Discussion
[Hypertension] Apr. 19 (Fri.) 11:10-12:40 103 (1F)
Resistant Hypertension
Chairperson(s)조명찬, 박창규
Panel 김원, 정우백, 조진만
11:10-11:30 How to Approach to Resistant Hypertension 임상현 / 가톨릭의대
11:30-11:50 How to Manage Resistant Hypertension 신진호 / 한양의대
11:50-12:20 Renal Nerve Denervation: Current and Future 김병극 / 연세의대
12:20-12:40 Discussion
[Cross Specialty: Intervention & Heart Failure] Apr. 19 (Fri.) 11:10-12:40 104 (1F)
Ischemic Cardiomyopathy: Case-Based Debate & Discussion
Chairperson(s)유규형, 권현철
Panel 김수중, 송영빈, 이상엽, 이혜원, 조재영, 최의영
11:10-11:22 Is This Patient Ischemic Cardiomyopathy? 김계훈 / 전남의대
11:22-11:30 Discussion
11:30-11:42 How to Evaluate the Myocardial Ischemia/Viability? 윤혁준 / 계명의대
11:42-11:50 Discussion
11:50-12:02 What Is the Optimal Medical Therapy? 유병수 / 연세원주의대
12:02-12:10 Discussion
12:10-12:22 If Amenable, How to Revascularize? 이주명 / 성균관의대
12:22-12:30 Discussion
12:30-12:40 Discussion
[Adult Congenital Heart Disease 1] Apr. 19 (Fri.) 11:10-12:40 106 (1F)
Lifelong Issues of Valves - How to Save the Pulmonary and Aortic Valves
Chairperson(s)현명철, 배은정
Panel 김중선, 박천수, 양지혁, 은영민, 장소익
11:10-11:25 Pulmonary Valve Disease in Adult 조익성 / 중앙의대
11:25-11:40 Pulmonary Valve Replacement for PS or PR with Surgery in CHD 이철 / 가톨릭의대
11:40-11:55 Pulmonary Valve Replacement for PS or PR with Transcatheter Intervention in CHD 최재영 / 연세의대
11:55-12:10 Bicuspid Aortic Valve 박성지 / 성균관의대
12:10-12:25 Aortic Valve Replacement with Transcatheter Intervention(TAVI) in Bicuspid Aortic Valve 홍범기 / 연세의대
12:25-12:40 Discussion
[Women Heart Disease] Apr. 19 (Fri.) 11:10-12:40 201 (2F)
Valvular Heart Disease in Women
Chairperson(s)김명아, 홍경순
Panel 김신재, 김학령, 설상훈, 윤현주
11:10-11:30 Gender Difference in Mitral Valve Disease 손일석 / 경희의대
11:30-11:50 Outcomes Following Valve Surgery 정동섭 / 성균관의대
11:50-12:10 TAVI and PMV 장기육 / 가톨릭의대
12:10-12:30 Management of Valvular Disease in Pregnancy 박성미 / 고려의대
12:30-12:40 Discussion
[Cardiac Pathology] Apr. 19 (Fri.) 11:10-12:40 203 (2F)
3D Modeling, 3D Printing, Virtual Reality and Real Hearts
Chairperson(s)김성호, 정해억
Panel 배장환, 송진영, 이창하, 조구영
11:10-11:25 Cross the Border Between the Real and the Virtual! 서정욱 / 서울의대
11:25-11:40 The Limitation of 2D Imaging. Why Do We Need 3D Imaging and 3D Printing? 윤연이 / 서울의대
11:40-11:55 3D Patient-Specific Digital Model from CT or MRI 이활 / 서울의대
11:55-12:10 Clinical Application of 3D Printing in Congenital Heart Disease 송미경 / 서울의대
12:10-12:25 3D Printing Application in Cardiac Surgery 윤태진 / 울산의대
12:25-12:40 Discussion
Scientific Session [Boryung] Apr. 19 (Fri.) 12:45-13:25 103 (1F)
Recent Results in Clinical Trials of Fimasartan in Essential Hypertension
Chairperson(s)정명호, 채인호
12:45-13:05 Beneficial Effect of Fimasartan in HTN Patients 박진주 / 서울의대
13:05-13:25 How to Achieve BP Control? The Answer Is Fimasartan Based SPC! 홍영준 / 전남의대
Scientific Session [BMS/Pfizer] Apr. 19 (Fri.) 12:45-13:25 104 (1F)
Managing AF Patient with Concomitant ACS/undergoing PCI : The AUGUSTUS Trial
Chairperson(s)김준수, 김효수
12:45-13:05 Antithrombotic Therapy in Patients with NVAF Undergoing PCI : Should We Change Our Practice? 강현재 / 서울의대
13:05-13:25 AUGUSTUS Trial : An Open-label, 2 x 2 Factorial, Randomized Trial to Evaluate the Safety of Apixaban vs.VKA and Aspirin vs. Placebo in Patients with AF and ACS and/or PCI Renato Delascio Lopes / Duke Univ., USA
Scientific Session [Samjin] Apr. 19 (Fri.) 12:45-13:25 106 (1F)
Prevention & Treatment for CardioMetabolic Syndrome
Chairperson(s)황교승, 구본권
12:45-13:05 Role of Clopidogrel in Coronary Artery Disease 김수중 / 경희의대
13:05-13:25 Stroke Prevention in Patients with Metabolic Syndrome and Atrial Fibrillation 김진석 / 고려의대
Scientific Session [MSD] Apr. 19 (Fri.) 12:45-13:25 201 (2F)
Protecting Patients with CVD in the Future
Chairperson(s)홍명기, 박헌식
12:45-13:05 The Benefit of Ezetimibe/atorvastantin Combination in Coronary Patients Treatment 정영훈 / 경상의대
13:05-13:25 New Treatment Option for SGLT2-Inhibitor in T2DM Patients-Ertugliflozin 배장환 / 충북의대
Scientific Session [Amgen] Apr. 19 (Fri.) 12:45-13:25 203 (2F)
PCSK9i (Evolocumab) : An Evolutionary Approach to Cardiovascular Therapeutics
Chairperson(s)정욱성, 김두일
12:45-13:05 The Positioning of PCSK9i in Updated Guidelines of Dyslipidemia 김병진 / 성균관의대
13:05-13:25 Clinical Evidence of Evolocumab and Its Practical Use 홍순준 / 고려의대
Diamond Session [Bayer] Apr. 19 (Fri.) 12:45-13:25 205 (2F)
Rivaroxaban, Decade of Consistency
Chairperson(s)이문형, 권현철
12:45-13:05 Consistent Safety Outcome of Rivaroxaban in NVAF Patients with Renal Impairment 최종일 / 고려의대
13:05-13:25 Safety Outcome of Rivaroxaban in AF Patient Undergoing PCI 박경우 / 서울의대
E [Memorial Lecture] Apr. 19 (Fri.) 13:40-14:30 205 (2F)
Chairperson(s)Kee Sik Kim
13:40-14:00 In Memory of Hi Myung Park Shung Chull Chae / Kyungpook National Univ., Korea
14:00-14:20 Revascularization in Heart Failure: What We Now Know and Need to Still Learn Eric Velaquez / Yale Univ.,USA
14:20-14:30 Discussion
[Myocardial Infarction 2] Apr. 19 (Fri.) 14:30-16:00 106 (1F)
Myocardial Infarction: Flash Debates in AMI
Chairperson(s)김종진, 차광수
Panel 김동기, 윤재용, 조진만, 허승호, 허정호
14:30-14:45 Fibrinolytic Therapy Versus Primary PCI in STEMI 심두선 / 전남의대
14:45-15:00 Can Beta-Blockers Be Terminated Post-MI? - Who Really Needs Them and How Long? 윤창환 / 서울의대
15:00-15:15 PCI Strategy in Multi Vessel Disease: How and When? 안성균 / 연세원주의대
15:15-15:30 Challenges in AMI: Personalized Cardiology in the Very Elderly Population 이상엽 / 충북의대
15:30-16:00 Discussion
[Basic Research 1] Apr. 19 (Fri.) 14:30-16:00 203 (2F)
Understanding Basics of Cardiovascular Research, Part I
Chairperson(s)안영근, 한진
Panel 권기환, 김기석, 민필기, 이상학, 주형준, 홍순준
14:30-14:50 Use of Animal Models in Cardiovascular Research 박훈준 / 가톨릭의대
14:50-15:10 Non-coding RNAs in Vascular Calcification 국현 / 전남의대
15:10-15:30 The Past, Present, and Future of Adult Stem Cell Research 권유욱 / 서울의대
15:30-16:00 Discussion
[Adult Congenital Heart Disease 2] Apr. 19 (Fri.) 16:10-17:40 106 (1F)
Incidentally Diagnosed Congenital Heart Disease: How to Treat and Follow-Up
Chairperson(s)박승우, 송종민
Panel 선병주, 송진영, 양동헌, 이미래
16:10-16:25 Atrial Septal Defect 강이석 / 성균관의대
16:25-16:40 Patent Ductus Arteriosus 박혁진 / 전남의대
16:40-16:55 Ventricular Septal Defect 최정현 / 부산의대
16:55-17:10 Anomalous Origin of Coronary Artery 김형관 / 서울의대
17:10-17:25 Persistent Foramen Ovale 나진오 / 고려의대
17:25-17:40 Discussion
[Cardiac Surgery] Apr. 19 (Fri.) 16:10-17:40 201 (2F)
Understanding the Valve Surgeries for Cardiologists - Surgical Video Session
Chairperson(s)나찬영, 조광조
Panel 김준성, 송승환, 신성호, 이해영, 홍준화
16:10-16:25 Cardiopulmonary Bypass Setup and Aortic Valve Replacement 박표원 / 성균관의대
16:25-16:35 Sutureless Aortic Valve Replacement 김경환 / 서울의대
16:35-16:45 Minimally Invasive Valve Surgery 제형곤 / 부산의대
16:45-16:55 Replacement of the Aortic Root (Bentall) 주현철 / 연세의대
16:55-17:05 Reimplantation of the Aortic Root (David) 주석중 / 울산의대
17:05-17:15 Totally Endoscopic Redo Mitral and Tricuspid Valve Surgery 유재석 / 세종병원
17:15-17:40 Discussion
[Basic Research 2] Apr. 19 (Fri.) 16:10-17:40 203 (2F)
Understanding Basics of Cardiovascular Research, Part II
Chairperson(s)오구택, 최동훈
Panel 기해진, 김용숙, 엄광현, 이찬주, 장우철, 허진
16:10-16:30 Practical Experience with Electrocardiography in Mouse 최종일 / 고려의대
16:30-16:50 Translational Research on Vaso-proliferative Retinopathy Using in Vivo Genome Editing 김정훈 / 서울의대
16:50-17:10 Understanding of Endothelial Mechanotransduction for Basic Researchers 우창훈 / 영남의대
17:10-17:40 Discussion
[Ethics Workshop] Apr. 19 (Fri.) 16:10-17:40 205 (2F)
늘어나는 의료분쟁과 의료현장에서 의료인폭행, 어떻게 이해할것인가?
Chairperson(s)김영대, 신동구
Panel 김형윤, 심지영, 황경국
16:10-16:30 의료분쟁의 현황과 원인 이동학 / 한국의료분쟁조정중재원
16:30-16:50 의료분쟁(사고)의 올바른 이해와 예방 윤태중 / 법무법인 태신
16:50-17:10 의료현장에서의 의료인에 대한 폭언과 폭행: 의료윤리적 대책 구영모 / 울산의대
17:10-17:30 임상윤리의 이해 권복규 / 이화의대
17:30-17:40 Discussion
[Imaging] Apr. 20 (Sat.) 09:00-10:30 103 (1F)
Imaging of Stable Coronary Artery Disease
Chairperson(s)송재관, 정정임
09:00-09:20 Diagnostic Approach of Stable Coronary Artery Disease 안정민 / 울산의대
09:20-09:40 Update of Cardiac CT for Stable Coronary Artery Disease 전은주 / 서울의대
09:40-10:00 CMR Perfusion and Viability 장성아 / 성균관의대
10:00-10:20 PET and Hybrid Imaging 강원준 / 연세의대
10:20-10:30 Discussion
[Smart Health] Apr. 20 (Sat.) 09:00-10:30 203 (2F)
Digital Cardiology Transformation
Chairperson(s)김용진, 김영학
Panel 김형섭, 박경우, 배장환
09:00-09:20 Potential Application of Brain-Computer Interface for Communication and Rehabiliation 임창환 / 한양대학교
09:20-09:40 노인 및 뇌졸중 환자의 보행 보조로봇 김연희 / 성균관의대
09:40-10:00 Multicenter Atrial Fibrillation Registry Study Using Common Data Model 조민수 / 울산의대
10:00-10:20 Global Digital Healthcare Service Development 김영인 / Noom코리아㈜
10:20-10:30 Discussion
[Cross Specialty: Arrhythmia & Heart Failure] Apr. 20 (Sat.) 09:00-09:45 205 (2F)
Debate 1: Primary Prevention ICDs in Patients with EF ≥ 35%
Chairperson(s)최동주, 오용석
Panel 백용수, 유희태, 정욱진, 최성훈
09:00-09:15 Pro. 박승정 / 성균관의대
09:15-09:30 Con. 박진주 / 서울의대
09:30-09:45 Discussion
[Cross Specialty: Arrhythmia & Heart Failure] Apr. 20 (Sat.) 09:45-10:30 205 (2F)
Debate 2: Atrial Fibrillation Ablation in Patients with Heart Failure
Chairperson(s)최동주, 오용석
Panel 양동헌, 유승기, 이소령, 이영수
09:45-10:00 Pro. 엄재선 / 연세의대
10:00-10:15 Con. 김인철 / 계명의대
10:15-10:30 Discussion
[Healthcare Policy] Apr. 20 (Sat.) 10:40-12:10 103 (1F)
심장질환 급성기 치료 관련 전문인력 적정화 방안
Chairperson(s)김기식, 김병옥
Panel 배장환, 안철민, 조덕규
10:40-10:55 전공의 수련특별법이 임상에 미치는 영향 장성인 / 연세의대
10:55-11:10 주 52시간 근로기준법 적용이 심혈관응급진료에 미치는 영향 문건웅 / 가톨릭의대
11:10-11:25 Hospitalist, 의료인력 공백의 현실적 대안인가? 김영삼 / 연세의대
11:25-12:10 Discussion
[Cross Specialty: Intervention & Imaging] Apr. 20 (Sat.) 10:40-12:10 104 (1F)
Beyond TAVR- Percutaneous Intervention in MV and TV
Chairperson(s)박승정, 최병욱
Panel 고영국, 김주한, 김형관, 손일석, 용환석
10:40-10:52 Recent Update in TAVR 2019: Interventionist Perspective 김효수 / 서울의대
10:52-11:04 Recent Update in TAVR 2019: Imaging Specialist Perspective 정정임 / 가톨릭의대
11:04-11:19 Discussion
11:19-11:31 Time to Start in Korea 박덕우 / 울산의대
11:31-11:43 ECHO Planning 홍그루 / 연세의대
11:43-11:55 CT Planning 양동현 / 울산의대
11:55-12:10 Discussion
Scientific Session [Hanmi] Apr. 20 (Sat.) 12:15-12:55 103 (1F)
New Insight on Intensive Treatment for Hypertension and Dyslipidemia Management
Chairperson(s)박창규, 최동훈
12:15-12:35 Evidence-based Approach for Ideal Hypertension Management 조구영 / 서울의대
12:35-12:55 Advantages of Rosuvastatin and Ezetimibe Combination Treatment 이무용 / 동국의대
Scientific Session [Bayer] Apr. 20 (Sat.) 12:15-12:55 104 (1F)
Tailored Protection for Your Cardio-vascular Patients
Chairperson(s)김기식, 오용석
12:15-12:35 Consideration of Renal Outcome in Anticoagulation Treatment in NVAF Patients with Renal Impairment 임홍의 / 한림의대
12:35-12:55 New Antithrombotic Treatment Strategies in Patients with Chronic CAD and PAD 김병극 / 연세의대
Scientific Session [Takeda/Dong-A ST] Apr. 20 (Sat.) 12:15-12:55 106 (1F)
The Way to Improve BP Control Rate
Chairperson(s)김철호, 조명찬
12:15-12:35 Differential Benefits and Real World Clinical Practices of Azilsartan Medoxomil 홍그루 / 연세의대
12:35-12:55 The 1st APC, Azilsartan Medoxomil/Chlorthalidone for Uncontrolled Hypertensive Patients 김용진 / 서울의대
Scientific Session [Novartis] Apr. 20 (Sat.) 12:15-12:55 201 (2F)
ARNI : PIONEER HF for Hospitalized Patients
Chairperson(s)전은석, 최동주
12:15-12:55 PIONEER-HF : Prime Time for ARNI in Stabilized AHF Patients Eric Velaquez / Yale Univ.,USA
Scientific Session [Daiichisankyo/ Daewoong] Apr. 20 (Sat.) 12:15-12:55 203 (2F)
Achieving Best Outcomes for Patients with Cardiovascular Disease with Edoxaban and Olmesartan
Chairperson(s)강석민, 편욱범
12:15-12:35 Translating RWE: Validating Safety and Effetiveness of NOACs in Clinical Tractice 최의근 / 서울의대
12:35-12:55 New Strategies to Improve Treatment Adherence in Hypertension 성지동 / 성균관의대
Diamond Session [BMS/Pfizer] Apr. 20 (Sat.) 12:15-12:55 205 (2F)
Leading Excellence for Stroke Prevention in NVAF
Chairperson(s)한성욱, 정보영
12:15-12:35 AUGUSTUS Trial : What Is the Optimal Antithrombotic Strategy for AF Patient Who Develop ACS Renato Delascio Lopes / Duke Univ., USA
12:35-12:55 Anticoagulation in AF with Comorbidities: “Fragile Patient” 배명환 / 경북의대
Scientific Session [Pfizer] Apr. 20 (Sat.) 12:15-12:55 211 (2F)
Strategies to Optimize Management of CVD
Chairperson(s)김영대
12:15-12:35 Highlighting 20 Years of CV Protection with Atorvastatin : Focusing on Secondary Prevention 남창욱 / 계명의대
12:35-12:55 Blood Pressure Variability : Its Prognostic Significance in CV Disease 손일석 / 경희의대
[Epidemiology] Apr. 20 (Sat.) 14:50-16:20 201 (2F)
Novel Biomarkers and Risk Factors for Heart Disease
Chairperson(s)김광일, 김현창
Panel 배장환, 손일석, 정선재
14:50-15:00 Systems Epidemiology Approach for Better CVD Prevention 김현창 / 연세의대
15:00-15:15 Stress Biomarkers and Cardiovascular Disease 이주미 / 을지의대
15:15-15:30 Immunosenescence & Inflammaing Biomarkers and Cardiovascular Disease 이원우 / 서울의대
15:30-15:45 Mebabolomics Approach to Biomarkers and Mechanisms of Cardiometabolic Disease 이상국 / 연세의대
15:45-16:00 Social Network Analysis and Cardiovascular Disease 염유식 / 연세대학교
16:00-16:20 Discussion